La Revas Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -60.79%
(FY 2021)
- Profit 29.61%
(FY 2021)
- Ebitda 28.60%
(FY 2021)
- Net Worth -75.20%
(FY 2021)
- Total Assets 6.02%
(FY 2021)
About La Revas Pharma
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Palas Paul, Biplab Nandi, Sujoy Mitra, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC313802
- Company No.
313802
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at La Revas Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Palas Paul  | Director | 10-Sep-2018 | Current |
| Biplab Nandi | Director | 10-Sep-2018 | Current |
| Sujoy Mitra | Director | 10-Sep-2018 | Current |
| Sandipan Chakraborty | Director | 10-Sep-2018 | Current |
| Syed Ali | Director | 10-Sep-2018 | Current |
Financial Performance of La Revas Pharma.
La Revas Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 60.79% decrease. The company also saw a substantial improvement in profitability, with a 29.61% increase in profit. The company's net worth observed a substantial decline by a decrease of 75.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of La Revas Pharma?
In 2021, La Revas Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Phoenix Hospital & Diagnostic Centre Private LimitedActive 24 years 9 monthsBiplab Nandi, Sujoy Mitra and 2 more are mutual person
Olivet Pharma Private LimitedActive 12 years 10 monthsBiplab Nandi, Sujoy Mitra and 2 more are mutual person
Elation Hair & Skin Clinic Private LimitedActive 9 years 6 monthsBiplab Nandi, Sujoy Mitra and 2 more are mutual person
Phoenix Medical Centre Private LimitedActive 2 years 11 monthsBiplab Nandi, Sujoy Mitra and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at La Revas Pharma?
La Revas Pharma has a workforce of 6 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of La Revas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped La Revas Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
